Trials / Completed
CompletedNCT02490891
Study of the Angiogenesis by PET/CT in Patients With Lymphoma
Study of the Angiogenesis Measured by PET/CT With 18F-RGD-K5 in Patients With Lymphoma : a Preliminary Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Centre Henri Becquerel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to measure tumoral angiogenesis modifications by RGD-K5 PET/CT before and after 2 cycles of chemotherapy in patients with lymphoma and a large tumoral mass
Detailed description
After inclusion PET scans with FDG tracer and with a specific tracer of angiogenesis will be performed on patient with lymphoma. After two cycles of chemotherapy PET scans with the same tracers will be performed. Overall survival and disease free survival will be monitored during 18 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RGD K5 PET scan | PET scan with a tracer specific for angiogenesis (RGD K5) will be performed before and after 2 cycles of chemotherapy |
Timeline
- Start date
- 2015-11-13
- Primary completion
- 2018-12-14
- Completion
- 2020-10-16
- First posted
- 2015-07-07
- Last updated
- 2026-01-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02490891. Inclusion in this directory is not an endorsement.